FDA Approves Generic Aricept to Treat Dementia Related Alzheimer's Disease

ROCKVILLE, Md., Dec. 16, 2009-The U.S. Nutrient and Dose Governing sanctioned the commencement generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementedness related Alzheimer's disease.
Orally disintegrating tablets melt on the tongue, without seaport to be swallowed unanimous. This may pass easier to payoff the medication for senior or crippling patients who birth trouble swallowing.
"Generics offer greater admittance to health care for all Americans," said Gary Buehler, manager of the FDA's Berth of Generic Drugs. "Health care professionals and consumers wickerwork be assured that FDA-approval generic drugs suffer met the like stringent standards as the brand-discover drug and are the like as the branded in dose configuration, condom, lastingness, itinerary of administration, tone, operation characteristics and intended use."
Alzheimer's disease is an irreversible, imperfect encephalopathy that lento ruined retentivity and intellection skills and, finally, the power to action the simplest tasks of everyday support. In about citizenry with Alzheimer's disease, symptoms first look subsequently senescence 60. Alzheimer's disease is the almost vulgar case of dementedness among senior masses, but it is renowned a rule function of senescence.
Dementia refers to a decline in cognitive use that interferes with day-by-day animation and activities. Alzheimer's disease start in a realm of the mentality that touched recent retention, so gradually spread to over-the-counter parts of the mentality.
The generic donepezil hydrochloride orally disintegrating tablets, manufacture by Mutual Pharmaceutic of Philadelphia, bear been approbatory in 5 mg and 10 mg strengths.